calendar
8,596 catalysts · 6,271 phase readout · 2,319 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,596 catalysts · 6,271 phase readout · 2,319 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Coronary Artery Disease
Sponsor: Sanofi. Phase: PHASE3. Conditions: Lichen Simplex Chronicus
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Cutaneous Melanoma
Sponsor: Rhode Island Hospital. Phase: NA. Conditions: HIV Prevention
Sponsor: Nurgul Ablakimova. Phase: NA. Conditions: Worsening Heart Failure, Congestion, Heart Failure
Sponsor: Universidade Federal Fluminense. Phase: NA. Conditions: Coronary Artery Disease (CAD), Oxidative Stress, Inflammation
Sponsor: Thomas Jefferson University. Phase: NA. Conditions: Opioid Use Disorder
Sponsor: Steffi Baker. Phase: . Conditions: Tourette Syndrome
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Brain Neoplasms, Endocrine System Diseases, Metabolic Diseases
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics). Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, NSCLC, PDAC - Pancreatic Ductal Adenocarcinoma, CRC (Colorectal Cancer), Metastatic Non-Small Lung Cell Cancer, Metastatic Colorectal Cancer (CRC), KRAS G12A, KRAS G12C, KRAS G12D, KRAS G12S, KRAS G12V, Metastatic Pancreatic Ductal Adenocarcinoma, Advanced Lung Carcinoma, Solid Tumor, Adult
Sponsor: Hacettepe University. Phase: NA. Conditions: Mucosal Wound, Mucosal Erosion, Mucosal Irritation, Endotracheal Intubation Fixation, Endotracheal Tube Position, Repositioning, Intensive Care Units (ICUs), Adult Patients, Pressure Ulcer Prevention
Sponsor: National University of Singapore. Phase: NA. Conditions: Coffee
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE1. Conditions: Bladder (Urothelial, Transitional Cell) Cancer
Sponsor: University of Bath. Phase: NA. Conditions: Glycaemic Index, Glycaemic Response Measurements
Sponsor: Johns Hopkins University. Phase: NA. Conditions: Obesity and Overweight
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. Phase: NA. Conditions: Pulmonary Embolism (PE)
Sponsor: Acera Surgical, Inc.. Phase: . Conditions: Surgical Wound
Sponsor: Rush Eye Associates. Phase: . Conditions: Cataract
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest. Phase: PHASE2. Conditions: Primary Myelofibrosis, Secondary Myelofibrosis
Sponsor: Institut Claudius Regaud. Phase: . Conditions: Ependymoma of Brain, Pediatric Solid Tumor
Sponsor: Aditi Bunker. Phase: NA. Conditions: Eco-anxiety, PTSD - Post Traumatic Stress Disorder, Resilience, Anxiety
Sponsor: University of South Florida. Phase: NA. Conditions: Alcohol Use Disorder
Sponsor: Wageningen University. Phase: NA. Conditions: Healthy, Type 2 Diabetes
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Obesity
Sponsor: Swiss Tropical & Public Health Institute. Phase: PHASE4. Conditions: Sickle Cell Disease (SCD)
Sponsor: Jamia Millia Islamia. Phase: NA. Conditions: Pulpitis - Irreversible
Sponsor: Johns Hopkins University. Phase: NA. Conditions: Dementia, Potentially Inappropriate Medication Use, Mild Cognitive Impairment (MCI)
Sponsor: David Lyubashevsky. Phase: PHASE4. Conditions: Transcatheter Aortic Valve Replacement (TAVR), Aortic Valve Stenosis
Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Pancreatitis, Chronic, Pancreatitis, Acute, Diabetes Mellitus
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer, Renal Carcinoma, Kidney Cancer Metastatic
Sponsor: Transcend Therapeutics. Phase: PHASE3. Conditions: Post Traumatic Stress Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: B-cell Acute Lymphoblastic Leukemia
Sponsor: University of Michigan. Phase: NA. Conditions: Depression and Quality of Life, Sexual Violence, PTSD, Suicidal Ideation, Problem Drinking
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Health Options, Strategic Care Planning
Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Non-dialysis Dependent Chronic Kidney Disease
Sponsor: Physicians Committee for Responsible Medicine. Phase: . Conditions: Food Acceptance, Soy Milk, Schools, New York, Acceptance, Choice, Beverage, Food Waste, Food Tasting
Sponsor: Vanderbilt University Medical Center. Phase: NA. Conditions: Acute Respiratory Failure
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Brain Metastases, Radionecrosis, Pulmonary Cancer
Sponsor: Seoul National University Hospital. Phase: . Conditions: Cardiac Arrest, Out-Of-Hospital
Sponsor: Virogen Biotechnology Inc.. Phase: PHASE2. Conditions: Mycosis Fungoides
Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc.. Phase: PHASE1. Conditions: Solid Tumors, Lymphomas
Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Mirogabalin, Pain
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Phase: NA. Conditions: Total Knee Arthroplasty
Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: Hearing Loss, Hearing Loss, Sensorineural, Deafness, Cochlear Implantation, Speech Perception
Sponsor: University of Sydney. Phase: PHASE3. Conditions: Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Glucose Intolerance, Obesity
Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy. Phase: PHASE4. Conditions: ASA Class III/IV Patients, COPD III/IV, Age 65 and Older, Multiple Organ Failure
Sponsor: Zhejiang Provincial Tongde Hospital. Phase: NA. Conditions: Alzheimer Disease, Cognitive Dysfunction, Mild Cognitive Impairment
Sponsor: Takeda. Phase: PHASE1. Conditions: Ketamine-Induced Brain Activity Changes, Psychotic-like Symptoms
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Adenocarcinoma